Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz‐1 domain

Journal of Thrombosis and Haemostasis - Tập 16 - Trang 893-904 - 2018
C. Augustsson1, A. Svensson1, B. Kjær1, T.‐Y. Chao2, X. Wenjuan2, B.O. Krogh1, J. Breinholt1, J.T. Clausen1, I. Hilden1, H.H. Petersen1, L.C. Petersen1
1Global Research, Novo Nordisk A/S, Måløv, Denmark
2Novo Nordisk Research Center China, Beijing, China

Tài liệu tham khảo

Rapaport, 1995, The tissue factor pathway: how it has become a “prima ballerina”, Thromb Haemost, 74, 7, 10.1055/s-0038-1642646 Monroe, 2007, The tissue factor‐factor VIIa complex: procoagulant activity, regulation, and multitasking, J Thromb Haemost, 5, 1097, 10.1111/j.1538-7836.2007.02435.x Osterud, 1977, Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation, Proc Natl Acad Sci U S A, 74, 5260, 10.1073/pnas.74.12.5260 Dahlback, 2005, Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases, J Intern Med, 257, 209, 10.1111/j.1365-2796.2004.01444.x Monroe, 2006, What does it take to make the perfect clot?, Arterioscler Thromb Vasc Biol, 26, 41, 10.1161/01.ATV.0000193624.28251.83 Girard, 1989, Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein, Thromb Res, 55, 37, 10.1016/0049-3848(89)90454-4 Broze, 1990, Regulation of coagulation by a multivalent Kunitz‐type inhibitor, Biochemistry, 29, 7539, 10.1021/bi00485a001 Baugh, 1998, Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor, J Biol Chem, 273, 4378, 10.1074/jbc.273.8.4378 Maroney, 2008, Expression of tissue factor pathway inhibitor by endothelial cells and platelets, Transfus Apher Sci, 38, 9, 10.1016/j.transci.2007.12.001 Broze, 2012, Tissue factor pathway inhibitor: structure‐function, Front Biosci (Landmark Ed), 17, 262, 10.2741/3926 Petersen, 1996, Inhibitory properties of separate recombinant Kunitz‐type‐protease‐inhibitor domains from tissue‐factor‐pathway inhibitor, Eur J Biochem, 235, 310, 10.1111/j.1432-1033.1996.0310f.x Peraramelli, 2013, Direct inhibition of factor VIIa by TFPI and TFPI constructs, J Thromb Haemost, 11, 704, 10.1111/jth.12152 Peraramelli, 2012, The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa, Thromb Haemost, 108, 266, 10.1160/TH11-12-0902 Hedner, 2011, First 20 years with recombinant FVIIa (NovoSeven), Haemophilia, 17, e172, 10.1111/j.1365-2516.2010.02352.x Erhardtsen, 1995, Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A, Blood Coagul Fibrinolysis, 6, 388, 10.1097/00001721-199507000-00004 Nordfang, 1991, Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma, Thromb Haemost, 66, 464, 10.1055/s-0038-1646439 Hilden, 2012, Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model, Blood, 119, 5871, 10.1182/blood-2012-01-401620 Chowdary, 2015, Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial, J Thromb Haemost, 13, 743, 10.1111/jth.12864 Johnson, 1998, Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor, Thromb Haemost, 80, 585 Petersen, 1992, Effect of leukocyte proteinases on tissue factor pathway inhibitor, Thromb Haemost, 67, 537, 10.1055/s-0038-1648489 Higuchi, 1992, The effect of leukocyte elastase on tissue factor pathway inhibitor, Blood, 79, 1712, 10.1182/blood.V79.7.1712.1712 Dockal, 2014, Small peptides blocking inhibition of factor Xa and tissue factor‐factor VIIa by tissue factor pathway inhibitor (TFPI), J Biol Chem, 289, 1732, 10.1074/jbc.M113.533836 Waters, 2013, Aptamer BAX 499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein, J Thromb Haemost, 11, 1137, 10.1111/jth.12201 Smith, 2004, Rapid and efficient incorporation of tissue factor into liposomes, J Thromb Haemost, 2, 1155, 10.1111/j.1538-7836.2004.00772.x Zhang, 1999, Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant, J Mol Biol, 285, 2089, 10.1006/jmbi.1998.2452 Berman, 2000, The protein data bank, Nucleic Acids Res, 28, 235, 10.1093/nar/28.1.235 Schrodinger LLC. The PyMOL Molecular Graphics System, Version 1.7.4. 2015. Peraramelli, 2014, Inhibition of tissue factor:factor VIIa‐catalyzed factor IX and factor X activation by TFPI and TFPI constructs, J Thromb Haemost, 12, 1826, 10.1111/jth.12713 Krishnaswamy, 1992, The interaction of human factor VIIa with tissue factor, J Biol Chem, 267, 23696, 10.1016/S0021-9258(18)35894-0 Hemker, 2003, Calibrated automated thrombin generation measurement in clotting plasma, Pathophysiol Haemost Thromb, 33, 4, 10.1159/000071636 Wun, 1988, Cloning and characterization of a cDNA coding for the lipoprotein‐associated coagulation inhibitor shows that it consists of three tandem Kunitz‐type inhibitory domains, J Biol Chem, 263, 6001, 10.1016/S0021-9258(18)68737-X Wesselschmidt, 1992, Tissue factor pathway inhibitor: the carboxy‐terminus is required for optimal inhibition of factor Xa, Blood, 79, 2004, 10.1182/blood.V79.8.2004.2004 Hackeng, 2006, Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor, Proc Natl Acad Sci U S A, 103, 3106, 10.1073/pnas.0504240103